The Harvard Drug Group LLC recalls
6 notices naming The Harvard Drug Group LLC as the recalling firm, since July 9, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
The Harvard Drug Group LLC: Omega-3-Acid
Hazard (FDA): Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
FDAMedicines
Dissolution
The Harvard Drug Group LLC: Memantine Hydrochloride Extended-Release
Hazard (FDA): Failed Dissolution Specifications
FDAMedicines
The Harvard Drug Group LLC: Midodrine Hydrochloride Tablets
Hazard (FDA): Defective container; inadequately sealed blister packaging.
FDAMedicines
The Harvard Drug Group LLC: Gabapentin Capsules and 1 more
Hazard (FDA): Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
FDAMedicines
The Harvard Drug Group LLC: Gabapentin Capsules and 1 more
Hazard (FDA): Defective container; blister packaging inadequately sealed.
FDAMedicines